SCHEMBL2443595

SCHEMBL2443595

Cc1cc(Cl)cc(/C=N\O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.41
ALDH1A1 P00352 8/20 0.40
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
PKM P14618 1/20 0.38
MAPT P10636 6/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 2/20 0.35
ACHE P22303 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2443599 1.00 HTT (0.41) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2161643 0.84 HTT (0.48) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2164984 0.84 HTT (0.43) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2164986 0.84 HTT (0.43) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL2161647 0.84 HTT (0.48) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL10889879 0.84 HTT (0.43) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL4047776 0.84 HTT (0.48) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL17725122 0.79 MAOB (0.48) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL16957828 0.76 RAPGEF4 (0.33) ALDH1A1MAPTMEN1KMT2ATSHR
SCHEMBL25370071 0.75 HTT (0.41) HTTALDH1A1CYP1A2CYP3A4PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed